{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 5587"}, "official-title": {"#tail": "\n\t", "#text": "To reduce opioid misuse and abuse."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140918", "#text": "September 18, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Foster", "@name-id": "F000454"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Sean Patrick Maloney of New York", "@name-id": "M001185"}, {"#tail": ", ", "#text": "Mr. Ryan of Ohio", "@name-id": "R000577"}, {"#tail": ", ", "#text": "Ms. Edwards", "@name-id": "E000290"}, {"#tail": ", and ", "#text": "Ms. Esty", "@name-id": "E000293"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Ms. Shea-Porter", "@name-id": "S001170"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H93B2674D497249C8BFB2E8AEABD7E4C6", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Opioid Abuse Prevention and Treatment Act of 2014", "@value": "Opioid Abuse Prevention and Treatment Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H484B2C2872D34C4486D85B9920E984C8"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Pilot project"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (referred to in this Act as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "quote": [{"#tail": ") shall award grants to one or more States to carry out a 1-year pilot project to develop a\n\t\t\t standardized peer review process and methodology to review and evaluate\n\t\t\t prescribing and pharmacy dispensing patterns, through a review of\n\t\t\t prescription drug monitoring programs (referred to in this section as ", "#text": "Secretary"}, {"#tail": ") in the States receiving such grants.", "#text": "PDMP"}]}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "#text": "\n        ", "@id": "HF8FCCB66EFDC4F2FBAC1DB89A45C4178", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The recipients of a grant under this section shall develop a systematic, standardized methodology\n\t\t\t to identify and investigate questionable or inappropriate prescribing and\n\t\t\t dispensing patterns of substances on schedule II or III under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ". Such peer review\n\t\t\t methodology and prescribing and dispensing patterns shall be shared with\n\t\t\t the appropriate State regulators and health profession boards.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202\n\t\t\t of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Methodology"}, "#text": "\n        ", "@id": "H8E72FD213B6240428146DF817829B594", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "A State receiving a grant under this section\u2014"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Requirements"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in order to prescribe such controlled\n\t\t\t substances, shall make the information with respect to such controlled\n\t\t\t substances from the PDMP available to State regulators and licensing\n\t\t\t boards; and", "@entity-type": "federal-body", "#text": "Drug Enforcement Administration", "@entity-id": "1524"}, "#text": "with respect to controlled substances for which a prescriber is required to be registered with by\n\t\t\t the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "HF1717F5018A24A9C98ACF182173EBE21", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "with respect to any other controlled substances, may make the information with respect to such\n\t\t\t controlled substances from the PDMP available to State regulators and\n\t\t\t licensing boards."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "H755379DF9FB14E1CB55A44B1EC1695DD", "@commented": "no"}], "#text": "\n        ", "@id": "HB09B3ED7F88A420BA8081821AA074E4D", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has entered into a contract under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A quality improvement organization with which the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " may\n\t\t\t serve as the subgrantee under this subsection to develop peer review\n\t\t\t processes as described in subsection (a).", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part\n\t\t\t B of title XI of the Social Security Act", "@value": "Social Security Act/t:XI/pt:B"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1320c et seq.", "@value": "usc/42/1320c/etseq"}, "@parsable-cite": "usc/42/1320c", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Subgrantees"}, "#text": "\n        ", "@id": "H85F44E5939394351B52B85105AA46E64", "@commented": "no"}], "#text": "\n      ", "@id": "H707DBE42B74B496991FAE173DADE3495", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the\n\t\t\t end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Part P of title III of the Public Health Service Act", "@value": "Public Health Service Act/t:III/pt:P"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "42 U.S.C. 280g", "@value": "usc/42/280g"}, "@parsable-cite": "usc/42/280g", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Prescription drug, heroin, and other controlled substance abuse prevention"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "399V\u20136."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Prescription drug, heroin, and other controlled substance abuse prevention"}, "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Training grants"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall award 5-year grants to eligible entities to facilitate training in order to\n\t\t\t increase the capacity of health care providers to conduct patient\n\t\t\t screening, brief interventions, and referral to treatment as needed, such\n\t\t\t as in health care settings to prevent the abuse of prescription drugs,\n\t\t\t heroin, and other controlled substances. The grant program under this\n\t\t\t section may be coordinated with the Screening Brief Intervention and\n\t\t\t Referral to Treatment grant program of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", or other appropriate programs.", "@entity-type": "federal-body", "#text": "Substance Abuse and Mental\n\t\t\t Health Services Administration", "@entity-id": "7522"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "H48B86BA7724741F99F3736CEC083297C", "@commented": "no"}, {"#tail": "\n          ", "@id": "HE9243783993B419CBC7EC747FA736F4B", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Eligible entities"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " includes\u2014", "#text": "eligible entity"}, "#text": "In this subsection, the term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "States;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "HF0C092D0EF584186A216C5FB29E39497", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "physician organizations;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H48FB455F44E741E0AFBA718A6EF0130B", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "continuing education entities, such as health profession boards or health accrediting bodies;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "#text": "\n                ", "@id": "HA78457CBD10340A281D368FE8CA62CB1", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "peer recovery organizations; and"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H89130B1DC36448648812AAD6FD61B162", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "other appropriate health or professional education organizations or institutions."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "#text": "\n                ", "@id": "H728EAB331DF545B8B0759C991A8EF382", "@commented": "no"}], "@commented": "no"}], "#text": "\n            ", "@id": "HAFEED553D4C843248D724DDF87A04F40", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall award grants to States for the purpose of evaluating\n\t\t\t the prospect of the health professions board of such States reviewing and\n\t\t\t expanding prescribing authorities of providers, such as advance practice\n\t\t\t nurses and physician's assistants, with respect to prescribing drugs for\n\t\t\t the treatment of the abuse of prescription drugs, heroin, or other\n\t\t\t controlled substances.", "@entity-type": "federal-body", "#text": "Administrator of the Health Resources and Services\n\t\t\t Administration", "@entity-id": "7526"}], "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Expansion of prescribing authority"}, "#text": "\n            ", "@id": "H1B7A04A06B94448DAAE65F0DA45FADFF", "@commented": "no"}], "#text": "\n          ", "@id": "H991DBD5EA5634286897EC9FE43C8221D"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HE356481021254CFA97F110DEBF22EB7E"}, "#text": "\n      ", "@id": "HFEE4CDBC03114B2882ADD4B91858474D", "@commented": "no"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Prescription drug abuse training and screening programs"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall award grants to States to develop continuing education criteria and review\n\t\t\t processes that allow State health profession boards or State agencies to\n\t\t\t certify appropriate education and training for informed and safe\n\t\t\t prescribing of opioids and other drugs listed on schedule II or III under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Continuing education grants"}, "#text": "\n        ", "@id": "HB6E762B3098046B4961E872632C39EFC", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall request that a practitioner registered under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " conduct patient screening for\n\t\t\t potential drug misuse or abuse before prescribing a drug listed on\n\t\t\t schedule II or III under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 303(f) of the\n\t\t\t Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:f"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 823(f)", "@value": "usc/21/823/f"}, "@parsable-cite": "usc/21/823", "#text": "\n            ", "@legal-doc": "usc"}}, {"#tail": ", according to standards established by the applicable State\n\t\t\t licensing body.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 202 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 812", "@value": "usc/21/812"}], "@entity-type": "law-citation", "#text": "\n            "}]}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Screening program"}, "#text": "\n        ", "@id": "H3EC26589D31E49FE89F60595357590F9", "@commented": "no"}], "#text": "\n      ", "@id": "H19170A069BF84D18B8FD86BA287EA26C"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall conduct a review of\n\t\t\t naloxone to consider whether naloxone should cease to be subject to\n\t\t\t ", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " and be available as an over-the-counter drug, in order to increase\n\t\t\t access to such drug.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 503(b) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 353(b)", "@value": "usc/21/353/b"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "FDA review of naloxone"}, "#text": "\n      ", "@id": "H8D358A7ECFDF43E5A8317FC80738291F"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall convene or coordinate with an existing entity an interagency working group\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Prescription drug disposal"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"#tail": " and fixed medicine disposal sites at law enforcement public buildings; and", "#text": "take-back programs"}, "#text": "to encourage States and local governments to increase opportunities for disposal of opiates, such\n\t\t\t as frequent "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H6F5D0232853E4BA9B98BFC7DE03C3124", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "to reduce opportunities for abuse of opiates, such as establishing opioid dispensing limits at\n\t\t\t hospital emergency departments."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H8C974F72450943AE931ED51F89F804CD", "#text": "\n        "}], "#text": "\n      ", "@id": "H222A5D740F974CA99E0170BB173B8AE7"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Comptroller General of the United States", "@entity-id": "0500"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "GAO report"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "review opioid abuse programs, heroin abuse programs, and policies in Federal agencies and best\n\t\t\t practices with respect to opioid and heroin abuse and overdose programs of\n\t\t\t the States; and"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H54FDCA5852AB46FEB723E18204C66039", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " on its\n\t\t\t findings and recommendations on ways to reduce opioid and heroin abuse and\n\t\t\t overdoses.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "not later than 18 months after the date of enactment of this Act, issue a report to "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H162FA33E4B2A463C93600E7ECCDEFAA3", "#text": "\n        "}], "#text": "\n      ", "@id": "HB6328140FE7F4776AF7BEC25372C4C15"}], "#text": "\n\t\t", "@id": "H79FAFB483EAF41A5BAE68F566C37EFE3"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-09-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5587 IH: Opioid Abuse Prevention and Treatment Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}